AstraZeneca heads to euros for more acquisition funding
![Pharma_drugs_adobe_575x375.jpg](https://assets.euromoneydigital.com/dims4/default/b01b394/2147483647/strip/true/crop/575x375+0+0/resize/840x548!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fe0%2F58%2F8ce0fc2a15cc3f1ce9a75517fd9a%2Fpharma-drugs-adobe-575x375.jpg)
AstraZeneca, the UK drug maker, hit the euro market on Wednesday after printing $7bn across the Atlantic a day earlier. The borrower is building up funds to pay for its $39bn acquisition of US rival Alexion Pharmaceuticals.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: